豚鼠结膜炎衣原体噬菌体phiCPG1衣壳蛋白Vp1的生物学作用
[Abstract]:Many human diseases are closely related to Chlamydia trachomatis (Ct) infection. Ct infection of conjunctiva can cause inclusion body conjunctivitis, trachoma and lung infection of infants and young children can cause pneumonia in infants and young children. Infection of urogenital tract can cause non-gonococcal urethritis, non-gonococcal vaginitis, cervicitis, venereal lymphadenitis. At present, many countries and regions sexually transmitted diseases (STD) are caused by CT. CT has become one of the main pathogens of STD in the world. STD caused by CT infection has become the most common STD in many countries and regions of Europe and the United States, and its incidence has exceeded that of gonorrhea. The number of genital Chlamydia trachomatis infections (GCI) is increasing year by year in China. Sexual transmission of Chlamydia trachomatis in female patients can lead to female vaginitis, endometritis, cervicitis, salpingitis, non-gonococcal urethritis, pelvic inflammation and ectopic pregnancy. Natural abortion, premature rupture of membranes, premature delivery, infertility and other adverse consequences, through vertical transmission will make the delivery of infected neonates infected with neonatal inclusion conjunctivitis [1].At present, due to the improper use of antibiotics in the treatment of CT infection is becoming increasingly serious, causing the problem of CT antibiotic resistance is becoming increasingly prominent, making it optional for treatment. So, experts and scholars all over the world are expecting to find new methods to prevent or treat Chlamydia trachomatis infection and to solve the problem of antibiotic resistance through further in-depth study of Chlamydia trachomatis infection. The researchers found that Chlamydia phages infect the host Chlamydia by binding to Chlamydia, which causes Chlamydia to stay in the reticulum stage and form abnormally enlarged reticulum, thus preventing the development of Chlamydia into mature protoplasts, reducing the number of protoplasts, greatly reducing the infectivity of Chlamydia, and even killing it. Chlamydia. Chlamydia, which is inhibited by interferon-gamma, also produces abnormally enlarged reticulae similar to those formed by Chlamydia after infection with phages. This suggests that phages may be able to treat CT infection clinically. Chlamydia phage capsid protein Vp1 is [Objective] To express, identify and purify the capsid protein Vp1 of Chlamydia conjunctivitis phage phi CPG1 from guinea pigs, and to culture E serotype and K serotype sand in cells. Chlamydia ophthalmica was used to intervene in the process of infection and observe its inhibitory effect on CT; Vp1 protein was used to treat E-type CT in the reproductive tract of mice, and its effect on the vaginal endothelium of the model mice was observed; Vp1 protein was used to treat K-type CT in the reproductive tract of mice, and its effect on Chlamydia trachomatis in the reproductive tract of the model mice was observed. [Methods] Chlamydia conjunctivitis phage phi CPG1 capsid protein Vp1 was expressed, identified and purified. The standard strains E, K and 100 ug/ml Vp1 of Chlamydia trachomatis were incubated at room temperature for 3 hours, respectively. The standard strains E and K of Chlamydia trachomatis were inoculated in monolayer dense Mc Coy cells and incubated in the whole sand. Vp1 protein was added to Chlamydia trachomatis culture and kept at 50 and 100 ug/ml. The number of inclusion bodies was counted by iodine staining to observe the inhibitory effect of Vp1 protein on the proliferation of Chlamydia trachomatis cultured in Mc Coy cells. The effect of Vp1 protein on the proliferation of Chlamydia trachomatis in vagina of mice was observed. A female BALB/c mouse model of K-type CT infection was established. Vp1 protein was given to the vagina at different intervals. The effects of Vp1 protein on the reproductive system inflammation induced by vaginal infection of Chlamydia trachomatis in mice were observed by pathological section of uterine horn, oviduct and ovary, and homogenate cell culture. The number of inclusion bodies of E-type and K-type standard strains was significantly reduced. The average number of inclusion bodies of the two standard strains was counted under each field of vision, and the inhibition rates of 100 ug/ml, 50 ug/ml Vp1, E-type 91%, 79%; K-type 94%, 70%. A female BALB/c mouse model of E-type standard strain CT was successfully constructed by intramuscular injection. Different concentrations of Vp1 protein were injected into the vagina and the vagina of mice at different time for cell culture and real-time quantitative PCR. There was no significant difference between the intramuscular injection group and the infection group. The concentration of Chlamydia in the high concentration group was lower than that in the low concentration group, and the concentration of Chlamydia in the low concentration group was lower than that in the infection group. The BALB/c female mice model of genital tract infection with standard strain CT of K type was successfully constructed. The reproductive system tissues of the mice were taken out 35 days after inoculation by Vp1 protein. The pathological observation of HE staining was carried out to evaluate the inflammation of uterine horn, fallopian tube and ovary. On the 7th day, the results of homogenate cell culture in the infected and intervention groups were all positive, but the results of oviduct and ovary were negative. On the 35th day, the corners of uterus, oviduct and ovary of the remaining mice in the infection group and intervention group were homogeneous. The results of plasma cell culture were negative. [Conclusion] The capsid protein Vp1 of Chlamydia conjunctivitis phi CPG1 can inhibit the proliferation of Chlamydia trachomatis in vitro. Vp1 can inhibit the proliferation of Chlamydia trachomatis in the vagina of infected mice and shorten the self-purification time of Chlamydia trachomatis in the vagina of mice. Vp1 protein can alleviate the inflammation of upper genital tract caused by Chlamydia trachomatis infection in mice.
【学位授予单位】:天津医科大学
【学位级别】:博士
【学位授予年份】:2017
【分类号】:R374.1
【相似文献】
相关期刊论文 前10条
1 张力;张晓楼;金秀英;;沙眼衣原体的研究进展[J];国外医学.眼科学分册;1988年04期
2 沐桂藩,吕华,徐如良,顾方舟;分泌抗沙眼衣原体单克隆抗体杂交瘤细胞株的建立[J];中国免疫学杂志;1989年04期
3 罗迪青,陈志和,翁智胜,彭洁雯,梁燕燕;1996~1997年305例淋病患者合并感染交原体及沙眼衣原体分析[J];临床皮肤科杂志;1998年06期
4 董植喜;沙眼衣原体入侵生殖道[J];家庭医学;2001年02期
5 陈继英;谨防沙眼衣原体“性骚扰”[J];医药世界;2000年04期
6 吴年浪,张惠成;荧光定量聚合酶链反应检测沙眼衣原体[J];眼科研究;2003年01期
7 陆金春,卫红英,尹兴昌;沙眼衣原体与沙眼的研究进展[J];临床眼科杂志;2003年06期
8 靳颖,王增田,董雪梅;沙眼衣原体的研究进展与优生[J];武警医学院学报;2004年03期
9 吴尚辉,陈明雄;723例健康体检者生殖道沙眼衣原体感染的调查[J];实用预防医学;2004年03期
10 高省,陈祥生;沙眼衣原体分子流行病学研究进展[J];国外医学.皮肤性病学分册;2004年06期
相关会议论文 前10条
1 江勇;杨丽娜;刘原君;刘全忠;;沙眼衣原体培养过程中耐甲氧西林表皮葡萄球菌污染的防控[A];中华医学会第16次全国皮肤性病学术年会摘要集[C];2010年
2 朱慧玲;李红梅;张勤奋;陈木开;韩建德;;沙眼衣原体持续感染模型及快速鉴定方法的研究[A];中华医学会第十八次全国皮肤性病学术年会论文汇编[C];2012年
3 刘全忠;;沙眼衣原体治疗现况和噬菌体的研究进展[A];中华医学会第16次全国皮肤性病学术年会摘要集[C];2010年
4 肖萌;刘全忠;;沙眼衣原体免疫优势蛋白的研究进展[A];中华医学会第十八次全国皮肤性病学术年会论文汇编[C];2012年
5 刘原君;齐蔓莉;绍丽丽;盛彩虹;姚卫锋;侯淑萍;刘全忠;;沙眼衣原体标准株不同型之间的差异性探讨[A];中华医学会第十五次全国皮肤性病学术会议论文集[C];2009年
6 刘全忠;江勇;侯淑萍;邵丽丽;杨晓静;杨丽娜;;迁延难愈沙眼衣原体泌尿生殖系感染的临床与实验研究[A];中华医学会第十五次全国皮肤性病学术会议论文集[C];2009年
7 杨斌;郑和平;薛耀华;吴兴中;江汉宁;黄进梅;;广州地区泌尿生殖道沙眼衣原体基因分型研究[A];2010全国中西医结合皮肤性病学术会议论文汇编[C];2010年
8 邵丽丽;江勇;杨丽娜;杨晓静;刘原君;刘全忠;;299例泌尿生殖道沙眼衣原体的检测及药物敏感性分析[A];中华医学会第十五次全国皮肤性病学术会议论文集[C];2009年
9 吴伊旋;陆平;沈志鸿;刘怡文;;272例泌尿生殖道感染沙眼衣原体或解脲支原体患者临床分析[A];2001年中国中西医结合皮肤性病学术会议论文汇编[C];2001年
10 刘全中;杨士强;傅志宜;王树椿;缴稳玲;田静群;;迁延难愈沙眼衣原体泌尿生殖道感染——几种抗生素的疗效评定和随访[A];2002中国中西医结合皮肤性病学术会议论文汇编[C];2002年
相关重要报纸文章 前10条
1 韩莉;“沙眼衣原体”也会入侵生殖系统[N];中国人口报;2006年
2 汪涛;孕妇感染沙眼衣原体危害大[N];大众卫生报;2007年
3 柯春荣;沙眼衣原体可导致不孕[N];大众卫生报;2003年
4 邓启泰;“沙眼衣原体”个头小危害大[N];医药养生保健报;2006年
5 韩丽;衣原体还能引起泌尿系感染[N];医药养生保健报;2007年
6 季建业;沙眼也可致性病[N];中国消费者报;2001年
7 凹凸;沙眼衣原体可致不孕[N];大众卫生报;2001年
8 江锦琦;女性感染沙眼衣原体可致不孕[N];中国中医药报;2001年
9 林国瑞;女性滥交易染衣原体[N];医药养生保健报;2007年
10 于泓珍;淋球菌与沙眼衣原体引起的感染[N];农村医药报(汉);2007年
相关博士学位论文 前10条
1 王生;豚鼠结膜炎衣原体噬菌体phiCPG1衣壳蛋白Vp1的生物学作用[D];天津医科大学;2017年
2 郭睿;衣原体噬菌体phiCPG1衣壳蛋白VP1的优化表达及其生物学效应的研究[D];天津医科大学;2017年
3 韩燕;泌尿生殖道沙眼衣原体多位点测序分型研究和新型变种流行现状研究[D];北京协和医学院;2016年
4 郭媛丽;衣原体噬菌体PhiCPG1衣壳蛋白Vp1对沙眼衣原体作用机制研究[D];天津医科大学;2016年
5 王千秋;泌尿生殖道沙眼衣原体感染的某些血清学和分子生物学研究[D];中国协和医科大学;1997年
6 李建红;沙眼衣原体高分辨率溶解曲线基因分型方法的建立及其在男男性行为者流行病学调查中的应用[D];北京协和医学院;2010年
7 江勇;沙眼衣原体临床株体外药物敏感性与耐药机制的研究[D];天津医科大学;2008年
8 粟玉珍;沙眼衣原体热休克蛋白60与免疫致病[D];中国医科大学;2002年
9 张磊;黑胸大蠊浓核病毒衣壳蛋白的表达与定位研究[D];武汉大学;2012年
10 高省;女性高危人群生殖道沙眼衣原体感染的分子流行病学研究[D];中国协和医科大学;2007年
相关硕士学位论文 前10条
1 汪咪珍;呼吸道感染患儿沙眼衣原体检测与基因分型[D];浙江大学;2015年
2 高磊琼;沙眼衣原体质粒致病机制分析[D];重庆医科大学;2015年
3 鲜雨琦;沙眼衣原体质粒在呼吸道感染中的作用及其机制初步研究[D];重庆医科大学;2016年
4 孙长贵;衣原体噬菌体衣壳蛋白Vp1对豚鼠结膜炎衣原体及沙眼衣原体的作用研究[D];天津医科大学;2016年
5 张新美;天津市性活跃人群血清沙眼衣原体免疫优势蛋白抗体的检测[D];天津医科大学;2016年
6 杨晓春;沙眼衣原体Ahpc基因克隆表达及过氧化物酶活性分析[D];南华大学;2015年
7 王威;泌尿生殖道感染沙眼衣原体多态膜蛋白F基因的多态性研究[D];河北医科大学;2016年
8 尤聪;沙眼衣原体培养阳性率提高及临床株热休克蛋白60的转录随传代的变化[D];天津医科大学;2012年
9 邵丽丽;沙眼衣原体抗菌素耐药及治疗失败的评估[D];天津医科大学;2010年
10 朱辉;大环内酯类药物次抑菌浓度诱导沙眼衣原体耐药的实验研究[D];天津医科大学;2010年
,本文编号:2180728
本文链接:https://www.wllwen.com/yixuelunwen/jichuyixue/2180728.html